E-Mail 'Bayer's Stivarga OK'd for Colon Cancer' To A Friend
Email a copy of 'Bayer's Stivarga OK'd for Colon Cancer' to a friend

Email a copy of 'Bayer's Stivarga OK'd for Colon Cancer' to a friend
(MedPage Today) — Regorafenib (Stivarga), an inhibitor of multiple kinase enzymes, has been approved for use in treatment-refractory, metastatic colorectal cancer, the FDA announced Thursday.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information:
verify here.